AMNEAL PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Tax Withholding Paid on Stock Awards of $44.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $176.00K, a 6.88% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $44.30M, a 104.75% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $321.00K, a 17.05% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $129.00K, a 33.51% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $22.28M, a 180.16% increase from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $7.95M, a 234.40% increase from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $2.38M, a 33.41% decline from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $3.57M, a 34.05% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $44.48M 10-Q · filed 2026-08-06 | $44.80M derived: sum of 3 quarters · filed 2026-08-06 | $44.93M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $44.30M 10-Q · filed 2026-05-07 | $44.63M derived: sum of 2 quarters · filed 2026-05-07 | $44.76M derived: sum of 3 quarters · filed 2026-05-07 | $44.94M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $450.00K derived: sum of 2 quarters · filed 2026-02-27 | $639.00K derived: sum of 3 quarters · filed 2026-08-06 | $22.28M 10-K · filed 2026-02-27 |
| 2025-09-30 | $129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $318.00K derived: sum of 2 quarters · filed 2026-08-06 | $21.96M 10-Q · filed 2025-11-06 | $22.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $189.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $21.83M 10-Q · filed 2026-08-06 | $22.21M derived: sum of 3 quarters · filed 2026-08-06 | $22.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $21.64M 10-Q · filed 2026-05-07 | $22.03M derived: sum of 2 quarters · filed 2026-05-07 | $22.22M derived: sum of 3 quarters · filed 2026-05-07 | $22.38M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $581.00K derived: sum of 2 quarters · filed 2026-02-27 | $740.00K derived: sum of 3 quarters · filed 2026-02-27 | $7.95M 10-K · filed 2026-02-27 |
| 2024-09-30 | $194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $353.00K derived: sum of 2 quarters · filed 2025-11-06 | $7.57M 10-Q · filed 2025-11-06 | $7.72M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $7.37M 10-Q · filed 2025-08-07 | $7.53M derived: sum of 3 quarters · filed 2026-02-27 | $7.72M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $7.21M 10-Q · filed 2025-05-07 | $7.37M derived: sum of 2 quarters · filed 2026-02-27 | $7.56M derived: sum of 3 quarters · filed 2026-02-27 | $7.57M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $345.00K derived: sum of 2 quarters · filed 2026-02-27 | $356.00K derived: sum of 3 quarters · filed 2026-02-27 | $2.38M 10-K · filed 2026-02-27 |
| 2023-09-30 | $189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $200.00K derived: sum of 2 quarters · filed 2024-11-12 | $2.22M 10-Q · filed 2024-11-12 | $2.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $2.03M 10-Q · filed 2024-08-09 | $2.12M derived: sum of 3 quarters · filed 2025-02-28 | $2.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $2.02M 10-Q · filed 2024-05-08 | $2.11M derived: sum of 2 quarters · filed 2025-02-28 | $2.30M derived: sum of 3 quarters · filed 2025-02-28 | $2.59M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $280.00K derived: sum of 2 quarters · filed 2025-02-28 | $570.00K derived: sum of 3 quarters · filed 2025-02-28 | $3.57M 10-K · filed 2025-02-28 |
| 2022-09-30 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $482.00K derived: sum of 2 quarters · filed 2023-11-09 | $3.48M 10-Q · filed 2023-11-09 | $3.55M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.29M 10-Q · filed 2023-08-08 | $3.36M derived: sum of 3 quarters · filed 2024-03-14 | $3.58M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-09 | $3.07M derived: sum of 2 quarters · filed 2024-03-14 | $3.29M derived: sum of 3 quarters · filed 2024-03-14 | $3.56M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $286.00K derived: sum of 2 quarters · filed 2024-03-14 | $562.00K derived: sum of 3 quarters · filed 2024-03-14 | $2.66M 10-K · filed 2024-03-14 |
| 2021-09-30 | $217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $493.00K derived: sum of 2 quarters · filed 2022-11-07 | $2.60M 10-Q · filed 2022-11-07 | $2.66M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.38M 10-Q · filed 2022-08-08 | $2.45M derived: sum of 3 quarters · filed 2023-03-03 | $2.68M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | $2.10M 10-Q · filed 2022-05-06 | $2.17M derived: sum of 2 quarters · filed 2023-03-03 | $2.41M derived: sum of 3 quarters · filed 2023-03-03 | $2.46M derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $306.00K derived: sum of 2 quarters · filed 2023-03-03 | $360.00K derived: sum of 3 quarters · filed 2023-03-03 | $863.00K 10-K · filed 2023-03-03 |
| 2020-09-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $292.00K derived: sum of 2 quarters · filed 2021-11-08 | $795.00K 10-Q · filed 2021-11-08 | $795.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $557.00K 10-Q · filed 2021-08-09 | $557.00K derived: sum of 3 quarters · filed 2022-03-01 | $562.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $503.00K 10-Q · filed 2021-05-07 | $503.00K derived: sum of 2 quarters · filed 2022-03-01 | $508.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.00K derived: sum of 2 quarters · filed 2022-03-01 | $926.00K derived: sum of 3 quarters · filed 2022-03-01 | $926.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $926.00K derived: sum of 2 quarters · filed 2020-11-06 | $926.00K 10-Q · filed 2020-11-06 | $926.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $921.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $921.00K 10-Q · filed 2020-08-06 | $921.00K derived: sum of 3 quarters · filed 2021-03-01 | $921.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |